Citation: T. Hokelek et al., Crystal structure of 3,4,6,7,15,16,17,18,19,20,21-undecahydro-2,5,6-trioxa-16,20-diazatricyclo[20.4.0.0(9,14)]hexacosa-9,11,13,22,24,26(1)-hexaene, ANAL SCI, 17(6), 2001, pp. 801-802
Citation: T. Hokelek et al., Crystal structure of 3,4,6,7,15,16,17,18,19,20,21,27-Dodecahydro-2,5,8-trioxa-16,20-diazatetracyclo[20.4.1.(16,20)0.0(9,14)]heptacosa-9,11,13,22,24,26(1)-hexaene, ANAL SCI, 17(3), 2001, pp. 465-466
Citation: T. Hokelek et al., Crystal structure of 15,21-bis(diethoxyphosphinoyl)-2,5,8-trioxa-16,20-diazatricyclo-[20.4.0.0(9,14)] hexacosa-9,11,13,22,24,26(1)-hexaene-ethylphosphonic acid-water (1/1/1), CRYST RES T, 36(4-5), 2001, pp. 509-515
Authors:
Mukaddes, NM
Bilge, S
Alyanak, B
Kora, ME
Citation: Nm. Mukaddes et al., Clinical characteristics and treatment responses in cases diagnosed as reactive attachment disorder, CHILD PSYCH, 30(4), 2000, pp. 273-287
Citation: T. Hokelek et al., 5,6,7,8,9,10,11,12,18,19,21,22-dodecahydro-8,9 : 18,19-dibenzo-1,4,7-trioxa-11,16-diazacyclononadeca-10,16-diene, ACT CRYST C, 55, 1999, pp. 381-383
Citation: T. Hokelek et al., 2,5,8-trioxa-16,20-diazabricyclo[20.4.0.0(9,14)]hexacosa-9,11,13,15,20,22,24,26-octaene, ACT CRYST C, 55, 1999, pp. 248-250